© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Sydney Jennings
Articles
FDA OKs First Biologic to Treat COPD with Eosinophilic Phenotype: Daily Dose
June 20, 2025
Your daily dose of the clinical news you may have missed.
Teledermatology-Dermoscopy Program Could Help Reduce Inequities in Skin Cancer Screening
June 20, 2025
A student-led teledermatology-dermoscopy initiative that identified skin lesions in underserved communities could be a scalable model for early skin cancer detection and care.
Atopic Dermatitis in Focus: 3 Expert Pearls for Primary Care
June 19, 2025
RAD 2025: Expert insights on the psychosocial burden of AD, flexible dosing, and cross-specialty collaboration in pediatric care.
Johann Gudjonsson, MD, PhD, on Emerging AD Therapies: From Single Targets to Combination Approaches
June 19, 2025
RAD 2025: Johann Gudjonsson, MD, PhD, on investigational AD treatments, including anti–IL-31 receptor antibodies, anti–IL-13 treatments, IL-4 receptor blockers, JAK inhibitors, and new topical agents.
Healthy Low-Carb or Low-Fat Diets Linked to Lower CVD Risk: Daily Dose
June 19, 2025
Your daily dose of the clinical news you may have missed.
FDA Clears Happy Ring for At-Home Diagnosis of Sleep Apnea and Insomnia
June 19, 2025
The FDA cleared Happy Ring, a wearable device for at-home diagnosis of sleep disorders, enhancing access to vital sleep health solutions.
PATHFINDER 2 Study Shows Improved Performance of Galleri Multicancer Detection Test
June 19, 2025
GRAIL announced that both cancer detection and positive predictive value with Galleri were substantially higher than in the earlier published PATHFINDER study.
When the Diagnosis is Topical Steroid Withdrawal Syndrome, a Compassionate, Collaborative History is Essential
June 19, 2025
RAD 2025: Brad Glick, DO, MPH, discusses the intensity of TSW symptoms and cautions against assuming there is mental health disturbance at work.
Coexisting HTN, T2D in US Adults Doubled Over 2 Decades: Daily Dose
June 18, 2025
Your daily dose of the clinical news you may have missed.
Johann Gudjonsson, MD, PhD: Role of OX-40 Pathway in Atopic Dermatitis Pathogenesis
June 18, 2025
Johann Gudjonsson, MD, discusses how OX-40/OX-40L signaling drives immune activation in AD and its emerging role as a genetic and therapeutic target.